世界の医薬品ろ過市場(~2028年):製品別(メンブレン、デプスフィルター)、用法別(使い捨て型、再利用型)、技術別(精密ろ過、ナノろ過)、用途別(API、ワクチン、抗体)、使用規模別(製造、パイロット、研究開発)、地域別

【英語タイトル】Pharmaceutical Filtration Market by Product (Membrane, Depth filter), System (Single use, Reusable), Technique (Microfiltration, Nanofiltration), Application (API, Vaccine, Antibody), Scale of Operation (Manufacturing, Pilot, R&D) & Region - Global Forecasts to 2028

MarketsandMarketsが出版した調査資料(BT4058-23)・商品コード:BT4058-23
・発行会社(調査会社):MarketsandMarkets
・発行日:2023年2月13日
・ページ数:433
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥984,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,206,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

MarketsandMarkets社の本レポートでは、世界の医薬品ろ過市場規模が2023年に135億ドルに達し、2028年までに262億ドルに拡大すると予想しています。また、予測期間中に年平均14.2%で成長すると展望しています。本調査レポートでは、医薬品ろ過の世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(フィルタ、システム、その他)分析、技術別(精密ろ過、限外ろ過、その他)分析、用途別(最終製品加工、原料ろ過、細胞分離、水質浄化、空気浄化)分析、種類別(無菌ろ過、非滅菌ろ過)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況、企業情報などの内容を掲載しています。参入企業情報として、Merck KGaA (Germany)、Danaher Corporation (US)、Sartorius AG (Germany)、Parker-Hannifin Corporation (US)、Thermo Fisher Scientific Inc. (US)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の医薬品ろ過市場規模:製品別
- フィルタの市場規模
- システムの市場規模
- その他の市場規模
・世界の医薬品ろ過市場規模:技術別
- 精密ろ過における市場規模
- 限外ろ過における市場規模
- その他における市場規模
・世界の医薬品ろ過市場規模:用途別
- 最終製品加工における市場規模
- 原料ろ過における市場規模
- 細胞分離における市場規模
- 水質浄化における市場規模
- 空気浄化における市場規模
・世界の医薬品ろ過市場規模:種類別
- 無菌ろ過の市場規模
- 非滅菌ろ過の市場規模
・世界の医薬品ろ過市場規模:地域別
- 北米の医薬品ろ過市場規模
- ヨーロッパの医薬品ろ過市場規模
- アジア太平洋の医薬品ろ過市場規模
- 中南米の医薬品ろ過市場規模
- 中東・アフリカの医薬品ろ過市場規模
・競争状況
・企業情報

” 医薬品ろ過市場は予測期間中14.2%のCAGRで成長する見込み”
2023年の市場規模は約135億米ドルと推定され、2028年には262億米ドルに達すると予測されています。医薬品ろ過市場の成長は、中国、インド、ブラジル、メキシコなどの新興国が大きな成長機会を提供していること、ナノファイバー技術の進歩、医薬品・バイオテクノロジー産業における製造と研究開発の増加などの要因によるものです。一方、膜のファウリングや、新しい生産設備の設置に必要な設備投資の増大は、市場成長の妨げになると予想されます。

“2022年、システム分野が医薬品市場で第2位のシェアを占める”
医薬品ろ過市場は、製品別にフィルター、システム、その他製品の大きく3つに区分されます。フィルター市場はさらに、メンブレンフィルター、デプスフィルター、プレフィルター、バッグフィルター、マグネットフィルターなどのその他のフィルターに区分されます。システム市場はさらに、シングルユースシステムと再利用可能システムに細分化されます。2022年には、システム部門が医薬品市場で第2位のシェアを占めました。このセグメントのシェアが大きいのは、主に分離・精製用途の重要性が高まっているためです。研究技術の発展や、ろ過プロセスにおける特異性への要求の高まりにより、多くの小規模バイオ医薬品プロセスでシングルユース技術の採用が増加しています。

“限外ろ過技術は、2022年にこの市場の第2位の市場シェアを占める”
技術に基づき、医薬品ろ過市場は精密ろ過、限外ろ過、ナノろ過、その他の技術に区分されます。その他の技術には、逆浸透とイオン交換が含まれます。精密ろ過技術は、2022年にこの市場の2番目に大きな市場シェアを占め、これは主に細胞採取と酵素精製血漿分離のための限外ろ過の実装に起因することができます。また、医薬品有効成分、培地・緩衝液、製剤、充填液のろ過にも使用されています。UFでは、精密ろ過では不可能なウイルス、ファージ、コロイド、高分子の除去がある程度可能なため、市場で大きなシェアを獲得しています。

“2022年、無菌ろ過技術がこの市場で最大の市場シェアを占める”
医薬品ろ過市場は、タイプに基づき、無菌ろ過と非無菌ろ過に区分されます。2022年には、無菌ろ過技術がこの市場で最大の市場シェアを占めました。これは、生物製剤の急成長、生物医薬品の液体処理中の無菌ろ過の要求の急増、無菌ろ過が非無菌ろ過よりも優れているなどの要因によるものです。
Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker-Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), 3M Company (US), Eaton Corporation plc (US), Donaldson Company, Inc. (US), Repligen Corporation (US), Porvair plc (UK), Alfa Laval Corporate AB (Sweden), Corning Incorporated (US), Meissner Filtration Products, Inc. (US), Amazon Filters Ltd. (UK), Graver Technologies, LLC (US), MMS AG (Switzerland), MANN+HUMMEL International GmbH & Co. KG (Germany), ErtelAlsop (US), Kasag Swiss AG (Switzerland), Freudenberg Filtration Technologies SE & Co. KG (Germany), Cole-Parmer Instrument Company, LLC. (US), Cantel Medical Corp. (US), Filtrox AG (Switzerland), Saint-Gobain Performance Plastics (France), and Membrane Solutions (US) は、医薬品ろ過市場で事業を展開する主要企業の一部です。

“アジア太平洋: 医薬品ろ過市場で最も急成長している地域”
医薬品ろ過市場は、北米、欧州、アジア太平洋、ラテンアメリカ(LATAM)、中東・アフリカ(MEA)に区分されます。アジア太平洋地域は、ウイルス性疾患の罹患率の増加、厳格な海外規制規則によるクリーンな製造環境の維持要件、ジェネリック医薬品製造の急速な拡大、ナノファイバー技術の開発、バイオ医薬品プロジェクトに対する研究開発費の増加、発展途上国におけるバイオテクノロジー産業の成長により、市場の急成長セグメントと推定されます。

本レポートのために実施した一次インタビューは以下のように分類されます:
- 回答者別 供給側80%、需要側20%
- 役職別 管理職 – 45%、CXOおよびディレクターレベル – 30%、経営幹部 – 25%
- 地域別 北米 -20%、欧州 -10%、アジア太平洋地域 -55%、RoW -15%

レポート掲載企業リスト
• Merck KGaA (Germany)
• Danaher Corporation (US)
• Sartorius AG (Germany)
• Parker-Hannifin Corporation (US)
• Thermo Fisher Scientific Inc. (US)
• 3M Company (US)
• Eaton Corporation plc (US)
• Donaldson Company, Inc. (US)
• Repligen Corporation (US)
• Porvair plc (UK)
• Alfa Laval Corporate AB (Sweden)
• Corning Incorporated (US)
• Meissner Filtration Products, Inc. (US)
• Amazon Filters Ltd. (UK)
• Graver Technologies, LLC (US)
• MMS AG (Switzerland)
• MANN+HUMMEL International GmbH & Co. KG (Germany)
• ErtelAlsop (US)
• Kasag Swiss AG (Switzerland)
• Freudenberg Filtration Technologies SE & Co. KG (Germany)
• Cole-Parmer Instrument Company, LLC. (US)
• Cantel Medical Corp. (US)
• Filtrox AG (Switzerland)
• Saint-Gobain Performance Plastics (France)
• Membrane Solutions (US)

調査範囲
この調査レポートは、医薬品ろ過市場の詳細な状況を掲載しています。製品、用途、エンドユーザー、地域など、さまざまなセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。また、主要な市場プレイヤーの企業プロフィールや最近の動向、主要な市場戦略とともに、詳細な競合分析も掲載しています。

レポート購入の主な利点
本レポートは、医薬品ろ過市場全体とそのサブセグメントにおける収益数の最も近い概算値を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競争状況をよりよく理解し、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるための洞察を深めるのにも役立ちます。本レポートは、関係者が市場の動向を理解し、主要な市場促進要因、阻害要因、課題、動向、機会に関する情報を提供することを可能にします。

❖ レポートの目次 ❖

1 INTRODUCTION 58
1.1 STUDY OBJECTIVES 58
1.2 MARKET DEFINITION 58
1.2.1 INCLUSIONS AND EXCLUSIONS 59
1.3 MARKET SCOPE 60
1.3.1 MARKETS COVERED 60
1.3.2 YEARS CONSIDERED 61
1.4 CURRENCY CONSIDERED 61
1.5 LIMITATIONS 61
1.6 STAKEHOLDERS 62
1.7 SUMMARY OF CHANGES 62
1.7.1 RECESSION IMPACT 63
2 RESEARCH METHODOLOGY 64
2.1 RESEARCH DATA 64
FIGURE 1 RESEARCH DESIGN 64
2.1.1 SECONDARY DATA 65
2.1.2 PRIMARY DATA 66
FIGURE 2 BREAKDOWN OF PRIMARIES, BY RESPONDENT, DESIGNATION, AND REGION 66
2.2 MARKET ESTIMATION METHODOLOGY 67
FIGURE 3 PHARMACEUTICAL FILTRATION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022 67
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 68
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 69
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 69
2.3 MARKET GROWTH RATE PROJECTIONS 70
FIGURE 6 PHARMACEUTICAL FILTRATION MARKET (SUPPLY SIDE): CAGR PROJECTIONS 71
FIGURE 7 PHARMACEUTICAL FILTRATION MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS 72
2.3.1 DATA TRIANGULATION 73
FIGURE 8 DATA TRIANGULATION METHODOLOGY 73
2.4 RESEARCH ASSUMPTIONS 74
2.5 IMPACT OF RECESSION 74
TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2024−2027 (% GROWTH) 74
2.6 RISK ANALYSIS 75

3 EXECUTIVE SUMMARY 76
FIGURE 9 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 76
FIGURE 10 PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 77
FIGURE 11 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION) 77
FIGURE 12 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 78
FIGURE 13 PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023 VS. 2028 (USD MILLION) 79
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF PHARMACEUTICAL FILTRATION MARKET 80
4 PREMIUM INSIGHTS 81
4.1 PHARMACEUTICAL FILTRATION MARKET OVERVIEW 81
FIGURE 15 INCREASING R&D SPENDING IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES TO DRIVE MARKET GROWTH 81
4.2 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT AND COUNTRY (2022) 82
FIGURE 16 FILTERS SEGMENT TO POSSESS LARGEST SHARE OF NORTH AMERICAN PHARMACEUTICAL FILTRATION MARKET IN 2022 82
4.3 PHARMACEUTICAL FILTRATION MARKET SHARE, BY APPLICATION (2023 VS. 2028) 82
FIGURE 17 FINAL PRODUCT PROCESSING APPLICATIONS SEGMENT TO DOMINATE MARKET IN 2028 82
4.4 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2022 (USD MILLION) 83
FIGURE 18 MICROFILTRATION SEGMENT TO DOMINATE MARKET, BY TECHNIQUE, IN 2022 83
4.5 PHARMACEUTICAL FILTRATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 84
FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2023 TO 2028 84
5 MARKET OVERVIEW 85
5.1 INTRODUCTION 85
5.2 MARKET DYNAMICS 85
FIGURE 20 PHARMACEUTICAL FILTRATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 85
TABLE 2 PHARMACEUTICAL FILTRATION MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 86
5.2.1 DRIVERS 87
5.2.1.1 Growing biopharmaceutical industry 87
TABLE 3 INDICATIVE LIST OF BIOLOGICAL LICENSE APPLICATION APPROVALS, 2021 AND 2022 87
5.2.1.2 Rising R&D spending in pharmaceutical and biotechnology industries 88
FIGURE 21 GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028 88
5.2.1.3 Increasing adoption of single-use technologies 88
5.2.1.4 New product launches by leading market players 89
5.2.1.5 Increasing purity requirements in end-user segments 90
5.2.2 RESTRAINTS 90
5.2.2.1 Membrane fouling issues 90
5.2.2.2 Requirement of high capital investments for new production facilities 90
5.2.3 OPPORTUNITIES 91
5.2.3.1 Growth opportunities in emerging economies 91
5.2.3.2 Advances in nanofiber technology 91
5.2.4 CHALLENGES 92
5.2.4.1 Increased cost and reduced speed and yield of filters 92
5.2.4.2 Survival of small players and new entrants 92
5.3 RANGES/SCENARIOS 93
FIGURE 22 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF PHARMACEUTICAL FILTRATION MARKET 93
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94
FIGURE 23 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PHARMACEUTICAL FILTRATION PRODUCT PROVIDERS 94
5.5 PRICING ANALYSIS 94
5.5.1 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS 94
TABLE 4 PRICE OF PHARMACEUTICAL FILTRATION PRODUCTS (2022) 94
5.5.2 AVERAGE SELLING PRICE TREND 94
5.6 VALUE CHAIN ANALYSIS 95
FIGURE 24 VALUE CHAIN ANALYSIS OF PHARMACEUTICAL FILTRATION MARKET 96
5.7 SUPPLY CHAIN ANALYSIS 96
FIGURE 25 PHARMACEUTICAL FILTRATION MARKET: SUPPLY CHAIN ANALYSIS 97
5.8 ECOSYSTEM ANALYSIS 98
FIGURE 26 ECOSYSTEM ANALYSIS: PHARMACEUTICAL FILTRATION MARKET 98
TABLE 5 SUPPLY CHAIN ECOSYSTEM 99
5.9 PATENT ANALYSIS 101
FIGURE 27 PATENT APPLICATIONS FOR PHARMACEUTICAL FILTRATION MARKET, JANUARY 2012–DECEMBER 2022 101
5.10 CASE STUDY ANALYSIS 101
5.10.1 IMPROVED CAPACITY AND EFFICIENCY OF CARBON REMOVAL PROCESS FROM ACTIVE PHARMACEUTICAL INGREDIENTS 101
5.10.2 FILTER HOUSING CAPABLE OF HANDLING BOTH GAS AND LIQUID 102
5.10.3 3M OFFERS EMPHAZE AEX HYBRID PURIFIER TO REDUCE IMPURITIES IN BIOPHARMACEUTICAL DOWNSTREAM PROCESS 102
5.10.4 DELIVERY OF POLYPROPYLENE PLEATED CARTRIDGES FOR HIGH-PURITY PHARMACEUTICAL PRODUCTS 102
5.10.5 USE OF POLYPROPYLENE HIGH-FLOW CARTRIDGE FOR FINAL FILTRATION PROCESS 102
5.11 KEY CONFERENCES AND EVENTS IN 2023 103
TABLE 6 PHARMACEUTICAL FILTRATION MARKET: LIST OF CONFERENCES AND EVENTS 103
5.12 REGULATORY ANALYSIS 104
5.12.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES 104
5.12.2 REGULATORY SCENARIO IN DIFFERENT REGIONS/COUNTRIES 105
5.13 PORTER’S FIVE FORCES ANALYSIS 106
TABLE 7 PHARMACEUTICAL FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS 106
5.13.1 THREAT OF NEW ENTRANTS 106
5.13.2 THREAT OF SUBSTITUTES 107
5.13.3 BARGAINING POWER OF BUYERS 107
5.13.4 BARGAINING POWER OF SUPPLIERS 107
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 107
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 108
5.14.1 KEY STAKEHOLDERS IN PHARMACEUTICAL COMPANIES AND THEIR INFLUENCE ON BUYING PROCESS 108
FIGURE 28 INFLUENCE OF STAKEHOLDERS IN PHARMACEUTICAL COMPANIES ON BUYING PROCESS OF PHARMACEUTICAL FILTRATION PRODUCTS 108
5.14.2 KEY BUYING CRITERIA FOR PHARMACEUTICAL FILTRATION PRODUCTS AMONG END USERS 108
FIGURE 29 KEY BUYING CRITERIA FOR END USERS 108
6 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT 109
6.1 INTRODUCTION 110
TABLE 8 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 110
6.2 FILTERS 110
TABLE 9 GLOBAL PHARMACEUTICAL FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 10 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 11 EUROPE: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 12 ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 13 LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 14 GLOBAL PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 113
6.2.1 MEMBRANE FILTERS 113
TABLE 15 GLOBAL PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 16 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 17 EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 18 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 19 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 20 PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 116
6.2.1.1 Polyethersulfone (PES) 116
TABLE 21 GLOBAL PES MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 117
TABLE 22 NORTH AMERICA: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 23 EUROPE: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 24 ASIA PACIFIC: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 25 LATIN AMERICA: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
6.2.1.2 Polyvinylidene difluoride (PVDF) 119
6.2.1.2.1 FDA, USP, and EEC compliance to increase demand for PVDF filters 119
TABLE 26 GLOBAL PVDF MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 27 NORTH AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 28 EUROPE: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 29 ASIA PACIFIC: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 30 LATIN AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
6.2.1.3 Nylon 121
6.2.1.3.1 Increased endotoxin adsorption capacity of nylon filters to drive growth 121
TABLE 31 GLOBAL NYLON MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 122
TABLE 32 NORTH AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 33 EUROPE: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 34 ASIA PACIFIC: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 35 LATIN AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
6.2.1.4 Polytetrafluoroethylene (PTFE) 123
6.2.1.4.1 PTFE membrane filters offer retention of ratings as fine as 0.01μ 123
TABLE 36 GLOBAL PTFE MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 124
TABLE 37 NORTH AMERICA: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 38 EUROPE: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 39 ASIA PACIFIC: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 40 LATIN AMERICA: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
6.2.1.5 Mixed cellulose ester & cellulose acetate (MCE & CA) 125
6.2.1.5.1 MCE membranes widely used in analytical and research applications 125
TABLE 41 GLOBAL MCE & CA MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 126
TABLE 42 NORTH AMERICA: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 43 EUROPE: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 44 ASIA PACIFIC: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 45 LATIN AMERICA: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
6.2.1.6 Polycarbonate track-etched (PCTE) 128
6.2.1.6.1 PCTE membrane filters widely used in cell biology and analytical testing applications 128
TABLE 46 GLOBAL PCTE MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 128
TABLE 47 NORTH AMERICA: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 48 EUROPE: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 49 ASIA PACIFIC: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 50 LATIN AMERICA: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
6.2.1.7 Other materials 130
TABLE 51 GLOBAL OTHER MATERIAL MEMBRANE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 131
TABLE 52 NORTH AMERICA: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 53 EUROPE: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 54 ASIA PACIFIC: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 55 LATIN AMERICA: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133
6.2.2 DEPTH FILTERS 133
TABLE 56 GLOBAL DEPTH FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 57 NORTH AMERICA: DEPTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 58 EUROPE: DEPTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 59 ASIA PACIFIC: DEPTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 60 LATIN AMERICA: DEPTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 61 DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 135
6.2.2.1 Diatomaceous earth 136
6.2.2.1.1 DE filters used in biotechnology industry for cell clarification 136
TABLE 62 GLOBAL DIATOMACEOUS EARTH FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 136
TABLE 63 NORTH AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 64 EUROPE: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 65 ASIA PACIFIC: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 66 LATIN AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 138
6.2.2.2 Cellulose 138
6.2.2.2.1 Cost-effectiveness of cellulose-based depth filters to drive growth 138
TABLE 67 GLOBAL CELLULOSE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 138
TABLE 68 NORTH AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 69 EUROPE: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 70 ASIA PACIFIC: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 71 LATIN AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 140
6.2.2.3 Activated carbon 140
6.2.2.3.1 Reliable and economic activated carbon filters to be used in traditional pharmaceutical manufacturing operations 140
TABLE 72 GLOBAL ACTIVATED CARBON FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 141
TABLE 73 NORTH AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 74 EUROPE: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 75 ASIA PACIFIC: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 76 LATIN AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143
6.2.2.4 Perlite 143
6.2.2.4.1 Lower density of perlite provides more purity than diatomaceous earth 143
TABLE 77 GLOBAL PERLITE FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 143
TABLE 78 NORTH AMERICA: PERLITE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 79 EUROPE: PERLITE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 80 ASIA PACIFIC: PERLITE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 81 LATIN AMERICA: PERLITE FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 145
6.2.2.5 Other depth filter media 145
TABLE 82 GLOBAL OTHER DEPTH FILTER MEDIA MARKET, BY REGION, 2021–2028 (USD MILLION) 145
TABLE 83 NORTH AMERICA: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 84 EUROPE: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 85 ASIA PACIFIC: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 86 LATIN AMERICA: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
6.2.3 OTHER FILTERS 147
TABLE 87 GLOBAL OTHER PHARMACEUTICAL FILTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 148
TABLE 88 NORTH AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 89 EUROPE: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 90 ASIA PACIFIC: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 91 LATIN AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150
6.3 SYSTEMS 150
TABLE 92 GLOBAL FILTRATION SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 150
TABLE 93 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 94 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 95 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 96 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 97 GLOBAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
6.3.1 SINGLE-USE SYSTEMS 153
6.3.1.1 Reduced need for product validation and minimized cross-contamination risk to boost adoption 153
TABLE 98 GLOBAL SINGLE-USE FILTRATION SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 153
TABLE 99 NORTH AMERICA: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 100 EUROPE: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 101 ASIA PACIFIC: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 102 LATIN AMERICA: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 155
6.3.2 REUSABLE SYSTEMS 155
6.3.2.1 Reusable systems widely used for large-scale manufacturing 155
TABLE 103 GLOBAL REUSABLE SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 155
TABLE 104 NORTH AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 105 EUROPE: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 106 ASIA PACIFIC: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 107 LATIN AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 157
6.4 OTHER FILTRATION PRODUCTS 157
TABLE 108 OTHER FILTRATION PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION) 158
TABLE 109 NORTH AMERICA: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 110 EUROPE: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 111 ASIA PACIFIC: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 112 LATIN AMERICA: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 113 OTHER FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
6.4.1 FILTRATION ASSEMBLIES 160
6.4.1.1 Leading players provide pre-assembled filtration assemblies 160
TABLE 114 GLOBAL FILTRATION ASSEMBLIES MARKET, BY REGION, 2021–2028 (USD MILLION) 161
TABLE 115 NORTH AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 116 EUROPE: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 162
TABLE 117 ASIA PACIFIC: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 162
TABLE 118 LATIN AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 163
6.4.2 FILTER HOLDERS 163
6.4.2.1 Filter holders provide structural support to membrane filters 163
TABLE 119 GLOBAL FILTER HOLDERS MARKET, BY REGION, 2021–2028 (USD MILLION) 163
TABLE 120 NORTH AMERICA: FILTER HOLDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 121 EUROPE: FILTER HOLDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 122 ASIA PACIFIC: FILTER HOLDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 123 LATIN AMERICA: FILTER HOLDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 165
6.4.3 FILTRATION ACCESSORIES 165
6.4.3.1 Increasing adoption of pharmaceutical filtration products to support growth 165
TABLE 124 GLOBAL PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION) 165
TABLE 125 NORTH AMERICA: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 126 EUROPE: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 127 ASIA PACIFIC: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 128 LATIN AMERICA: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 167
7 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE 168
7.1 INTRODUCTION 169
TABLE 129 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 169
7.2 MICROFILTRATION 169
7.2.1 INCREASED ADOPTION OF MICROFILTRATION TO PROPEL MARKET GROWTH 169
TABLE 130 GLOBAL MICROFILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 170
TABLE 131 NORTH AMERICA: MICROFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 132 EUROPE: MICROFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 133 ASIA PACIFIC: MICROFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 134 LATIN AMERICA: MICROFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171
7.3 ULTRAFILTRATION 171
7.3.1 ADOPTION OF FINE FILTRATION TECHNIQUES TO DRIVE GROWTH 171
TABLE 135 GLOBAL ULTRAFILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 172
TABLE 136 NORTH AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 137 EUROPE: ULTRAFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 138 ASIA PACIFIC: ULTRAFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 139 LATIN AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173

7.4 NANOFILTRATION 174
7.4.1 HIGH ENERGY CONSUMPTION TO HINDER MARKET GROWTH 174
TABLE 140 GLOBAL NANOFILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 174
TABLE 141 NORTH AMERICA: NANOFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 142 EUROPE: NANOFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 143 ASIA PACIFIC: NANOFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 144 LATIN AMERICA: NANOFILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 176
7.5 OTHER TECHNIQUES 176
TABLE 145 GLOBAL OTHER TECHNIQUES MARKET, BY REGION, 2021–2028 (USD MILLION) 176
TABLE 146 NORTH AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 147 EUROPE: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 148 ASIA PACIFIC: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 178
TABLE 149 LATIN AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 178
8 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION 179
8.1 INTRODUCTION 180
TABLE 150 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 180
8.2 FINAL PRODUCT PROCESSING 180
TABLE 151 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY REGION, 2021–2028 (USD MILLION) 181
TABLE 152 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 153 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 182
TABLE 154 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 182
TABLE 155 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 183
TABLE 156 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 183
8.2.1 ACTIVE PHARMACEUTICAL INGREDIENT (API) FILTRATION 183
8.2.1.1 Continuous requirement for API filtration to drive market growth 183
TABLE 157 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 184
TABLE 158 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 159 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 185
TABLE 160 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 185
TABLE 161 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 186
8.2.2 PROTEIN PURIFICATION 186
8.2.2.1 Recent advancements in protein therapeutic drugs to propel growth 186
TABLE 162 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY REGION, 2021–2028 (USD MILLION) 187
TABLE 163 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 187
TABLE 164 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 188
TABLE 165 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 188
TABLE 166 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 189
8.2.3 VACCINE AND ANTIBODY PROCESSING 189
8.2.3.1 Development of vaccines for COVID-19 and other viral diseases to drive growth 189
TABLE 167 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY REGION, 2021–2028 (USD MILLION) 189
TABLE 168 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 190
TABLE 169 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 190
TABLE 170 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 191
TABLE 171 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021–2028 (USD MILLION) 191
8.2.4 FORMULATION AND FILLING SOLUTIONS 191
8.2.4.1 Demand for aseptic filling and bioburden reduction to propel growth 191
TABLE 172 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY REGION, 2021–2028 (USD MILLION) 192
TABLE 173 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 192
TABLE 174 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 193
TABLE 175 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 193
TABLE 176 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 194
8.2.5 VIRAL CLEARANCE 194
8.2.5.1 Growing development of therapeutic monoclonal antibodies to drive market 194
TABLE 177 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY REGION, 2021–2028 (USD MILLION) 195
TABLE 178 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021–2028 (USD MILLION) 195
TABLE 179 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021–2028 (USD MILLION) 196
TABLE 180 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021–2028 (USD MILLION) 196
TABLE 181 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021–2028 (USD MILLION) 197
8.3 RAW MATERIAL FILTRATION 197
TABLE 182 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY REGION, 2021–2028 (USD MILLION) 197
TABLE 183 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 198
TABLE 184 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 198
TABLE 185 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 199
TABLE 186 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 199
TABLE 187 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 199
8.3.1 MEDIA BUFFER FILTRATION 200
8.3.1.1 Growth in manufacturing of biopharmaceuticals to drive market 200
TABLE 188 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY REGION, 2021–2028 (USD MILLION) 200
TABLE 189 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 201
TABLE 190 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 201
TABLE 191 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 202
TABLE 192 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 202
8.3.2 PREFILTRATION 203
8.3.2.1 Membrane fouling issues to drive growth 203
TABLE 193 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY REGION, 2021–2028 (USD MILLION) 203
TABLE 194 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 203
TABLE 195 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 204
TABLE 196 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 204
TABLE 197 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021–2028 (USD MILLION) 205
8.3.3 BIOBURDEN TESTING 205
8.3.3.1 Strict quality control of biopharmaceuticals to drive growth 205
TABLE 198 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY REGION, 2021–2028 (USD MILLION) 205
TABLE 199 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 206
TABLE 200 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 206
TABLE 201 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 207
TABLE 202 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 207
8.4 CELL SEPARATION 208
8.4.1 GROWTH IN PERSONALIZED MEDICINE TO PROPEL MARKET 208
TABLE 203 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY REGION, 2021–2028 (USD MILLION) 208
TABLE 204 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 208
TABLE 205 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 209
TABLE 206 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 209
TABLE 207 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 210
8.5 WATER PURIFICATION 210
8.5.1 GROWTH IN GERIATRIC POPULATION TO DRIVE MARKET 210
TABLE 208 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY REGION, 2021–2028 (USD MILLION) 210
TABLE 209 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 211
TABLE 210 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 211
TABLE 211 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 212
TABLE 212 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 212
8.6 AIR PURIFICATION 212
8.6.1 INCREASING ADOPTION OF GMP PRACTICES TO DRIVE GROWTH 212
TABLE 213 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY REGION, 2021–2028 (USD MILLION) 213
TABLE 214 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 213
TABLE 215 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 214
TABLE 216 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 214
TABLE 217 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021–2028 (USD MILLION) 215

9 PHARMACEUTICAL FILTRATION MARKET, BY TYPE 216
9.1 INTRODUCTION 217
TABLE 218 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
9.2 STERILE FILTRATION 217
9.2.1 ADVANTAGES OF STERILE FILTERS OVER NON-STERILE FILTERS TO DRIVE GROWTH 217
TABLE 219 GLOBAL STERILE FILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 218
TABLE 220 NORTH AMERICA: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 218
TABLE 221 EUROPE: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 218
TABLE 222 ASIA PACIFIC: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 219
TABLE 223 LATIN AMERICA: STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 219
9.3 NON-STERILE FILTRATION 219
9.3.1 GROWTH IN PHARMA R&D ACTIVITIES TO PROMOTE MARKET GROWTH 219
TABLE 224 GLOBAL NON-STERILE FILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 220
TABLE 225 NORTH AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 220
TABLE 226 EUROPE: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 221
TABLE 227 ASIA PACIFIC: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 221
TABLE 228 LATIN AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 222
10 PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION 223
10.1 INTRODUCTION 224
TABLE 229 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 224
10.2 MANUFACTURING-SCALE OPERATION 224
10.2.1 GROWTH IN BIOLOGICS AND BIOSIMILARS MANUFACTURING TO DRIVE MARKET 224
TABLE 230 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY REGION, 2021–2028 (USD MILLION) 225
TABLE 231 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 226
TABLE 232 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 226
TABLE 233 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 227
TABLE 234 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 227
10.3 PILOT-SCALE OPERATION 227
10.3.1 INCREASED OUTSOURCING TO DRIVE MARKET GROWTH 227
TABLE 235 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY REGION, 2021–2028 (USD MILLION) 228
TABLE 236 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 228
TABLE 237 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 229
TABLE 238 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 229
TABLE 239 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 230
10.4 R&D-SCALE OPERATION 230
10.4.1 INCREASING INVESTMENTS IN R&D OF BIOLOGICS TO PROPEL GROWTH 230
TABLE 240 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY REGION, 2021–2028 (USD MILLION) 231
TABLE 241 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 231
TABLE 242 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 232
TABLE 243 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 232
TABLE 244 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2021–2028 (USD MILLION) 233
11 PHARMACEUTICAL FILTRATION MARKET, BY REGION 234
11.1 INTRODUCTION 235
TABLE 245 PHARMACEUTICAL FILTRATION MARKET, BY REGION, 2021–2028 (USD MILLION) 235
11.2 NORTH AMERICA 235
FIGURE 30 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET SNAPSHOT 236
TABLE 246 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 237
TABLE 247 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 237
TABLE 248 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 249 NORTH AMERICA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 238
TABLE 250 NORTH AMERICA: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 238
TABLE 251 NORTH AMERICA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 239
TABLE 252 NORTH AMERICA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 239
TABLE 253 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 239
TABLE 254 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 255 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 240
TABLE 256 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 241
TABLE 257 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 241
TABLE 258 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 242
11.2.1 US 242
11.2.1.1 US to dominate North American market during forecast period 242
FIGURE 31 US TO DOMINATE DISTRIBUTION OF R&D COMPANIES (2022) 243
TABLE 259 US: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 243
TABLE 260 US: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 261 US: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 244
TABLE 262 US: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 244
TABLE 263 US: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 245
TABLE 264 US: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 245
TABLE 265 US: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 245
TABLE 266 US: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 267 US: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 246
TABLE 268 US: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 269 US: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 270 US: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 248
11.2.2 CANADA 248
11.2.2.1 Growing government support for expanding biologics manufacturing facilities to support market growth 248
TABLE 271 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 249
TABLE 272 CANADA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 249
TABLE 273 CANADA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 249
TABLE 274 CANADA: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 250
TABLE 275 CANADA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 250
TABLE 276 CANADA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 250
TABLE 277 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 251
TABLE 278 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 251
TABLE 279 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 251
TABLE 280 CANADA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 281 CANADA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 282 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 253
11.2.3 NORTH AMERICA: RECESSION IMPACT 253
11.3 EUROPE 254
TABLE 283 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 254
TABLE 284 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 255
TABLE 285 EUROPE: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 286 EUROPE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 255
TABLE 287 EUROPE: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 256
TABLE 288 EUROPE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 289 EUROPE: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 290 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 257
TABLE 291 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 292 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 257
TABLE 293 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 294 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 295 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 259
11.3.1 GERMANY 259
11.3.1.1 Growing pharmaceutical R&D and manufacturing to drive market 259
TABLE 296 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 260
TABLE 297 GERMANY: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 260
TABLE 298 GERMANY: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 261
TABLE 299 GERMANY: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 261
TABLE 300 GERMANY: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 301 GERMANY: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 302 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 262
TABLE 303 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 263
TABLE 304 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 263
TABLE 305 GERMANY: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 264
TABLE 306 GERMANY: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 264
TABLE 307 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 265
11.3.2 UK 265
11.3.2.1 Increased R&D investment and government aid to boost market growth 265
TABLE 308 UK: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 266
TABLE 309 UK: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 266
TABLE 310 UK: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 266
TABLE 311 UK: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 267
TABLE 312 UK: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 313 UK: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 314 UK: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 268
TABLE 315 UK: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 316 UK: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 268
TABLE 317 UK: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 269
TABLE 318 UK: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 269
TABLE 319 UK: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 270
11.3.3 FRANCE 270
11.3.3.1 Government investment in pharmaceutical industry to drive growth 270
TABLE 320 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 271
TABLE 321 FRANCE: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 271
TABLE 322 FRANCE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 272
TABLE 323 FRANCE: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 272
TABLE 324 FRANCE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 273
TABLE 325 FRANCE: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 273
TABLE 326 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 273
TABLE 327 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 274
TABLE 328 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 274
TABLE 329 FRANCE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 275
TABLE 330 FRANCE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 275
TABLE 331 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 276
11.3.4 ITALY 276
11.3.4.1 Investment in biotechnology R&D to boost market growth 276
TABLE 332 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 276
TABLE 333 ITALY: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 277
TABLE 334 ITALY: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 277
TABLE 335 ITALY: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 278
TABLE 336 ITALY: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 278
TABLE 337 ITALY: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 278
TABLE 338 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 279
TABLE 339 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 279
TABLE 340 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 279
TABLE 341 ITALY: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 280
TABLE 342 ITALY: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 280
TABLE 343 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 281
11.3.5 SPAIN 281
11.3.5.1 Expansion of biomanufacturing facilities to support market growth 281
TABLE 344 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 282
TABLE 345 SPAIN: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 282
TABLE 346 SPAIN: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 282
TABLE 347 SPAIN: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 283
TABLE 348 SPAIN: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 283
TABLE 349 SPAIN: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 283
TABLE 350 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 284
TABLE 351 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 284
TABLE 352 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 284
TABLE 353 SPAIN: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 285
TABLE 354 SPAIN: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 285
TABLE 355 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 286
11.3.6 REST OF EUROPE 286
TABLE 356 ROE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 287
TABLE 357 ROE: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 287
TABLE 358 ROE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 287
TABLE 359 ROE: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 288
TABLE 360 ROE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 288
TABLE 361 ROE: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 288
TABLE 362 ROE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 289
TABLE 363 ROE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 289
TABLE 364 ROE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 289
TABLE 365 ROE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 290
TABLE 366 ROE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 290
TABLE 367 ROE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 291
11.3.7 EUROPE: RECESSION IMPACT 291

11.4 ASIA PACIFIC 291
FIGURE 32 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET SNAPSHOT 292
TABLE 368 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 293
TABLE 369 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 293
TABLE 370 ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 294
TABLE 371 ASIA PACIFIC: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 294
TABLE 372 ASIA PACIFIC: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 295
TABLE 373 ASIA PACIFIC: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 295
TABLE 374 ASIA PACIFIC: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 295
TABLE 375 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 296
TABLE 376 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 296
TABLE 377 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 297
TABLE 378 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 297
TABLE 379 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 298
TABLE 380 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 298
11.4.1 CHINA 298
11.4.1.1 Shift from generic medicine to innovative drugs to drive market for advanced pharmaceutical filtration 298
TABLE 381 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 299
TABLE 382 CHINA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 299
TABLE 383 CHINA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 300
TABLE 384 CHINA: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 300
TABLE 385 CHINA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 301
TABLE 386 CHINA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 301
TABLE 387 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 301
TABLE 388 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 302
TABLE 389 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 302
TABLE 390 CHINA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 303
TABLE 391 CHINA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 303
TABLE 392 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 304
11.4.2 JAPAN 304
11.4.2.1 Stringent regulatory guidelines to create need for advanced filtration products 304
TABLE 393 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 305
TABLE 394 JAPAN: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 305
TABLE 395 JAPAN: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 306
TABLE 396 JAPAN: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 306
TABLE 397 JAPAN: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 307
TABLE 398 JAPAN: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 307
TABLE 399 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 307
TABLE 400 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 308
TABLE 401 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 308
TABLE 402 JAPAN: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 309
TABLE 403 JAPAN: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 309
TABLE 404 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 310
11.4.3 INDIA 310
11.4.3.1 Government initiatives and competitive nature of Indian pharmaceutical market to drive growth 310
TABLE 405 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 311
TABLE 406 INDIA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 311
TABLE 407 INDIA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 311
TABLE 408 INDIA: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 312
TABLE 409 INDIA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 312
TABLE 410 INDIA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 312
TABLE 411 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 313
TABLE 412 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 313
TABLE 413 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 313
TABLE 414 INDIA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 314
TABLE 415 INDIA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 314
TABLE 416 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 315
11.4.4 SOUTH KOREA 315
11.4.4.1 Increased export of drugs to affect market growth 315
TABLE 417 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 315
TABLE 418 SOUTH KOREA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 316
TABLE 419 SOUTH KOREA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 316
TABLE 420 SOUTH KOREA: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 317
TABLE 421 SOUTH KOREA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 317
TABLE 422 SOUTH KOREA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 317
TABLE 423 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 318
TABLE 424 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 318
TABLE 425 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 319
TABLE 426 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 319
TABLE 427 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 320
TABLE 428 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 320
11.4.5 REST OF ASIA PACIFIC 320
TABLE 429 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 321
TABLE 430 ROAPAC: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 321
TABLE 431 ROAPAC: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 322
TABLE 432 ROAPAC: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 322
TABLE 433 ROAPAC: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 323
TABLE 434 ROAPAC: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 323
TABLE 435 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 323
TABLE 436 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 324
TABLE 437 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 324
TABLE 438 ROAPAC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 325
TABLE 439 ROAPAC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 325
TABLE 440 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 326
11.4.6 ASIA PACIFIC: RECESSION IMPACT 326
11.5 LATIN AMERICA 327
TABLE 441 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 327
TABLE 442 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 327
TABLE 443 LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 328
TABLE 444 LATIN AMERICA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 328
TABLE 445 LATIN AMERICA: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 329
TABLE 446 LATIN AMERICA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 329
TABLE 447 LATIN AMERICA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 329
TABLE 448 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 330
TABLE 449 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 330
TABLE 450 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 331
TABLE 451 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 331
TABLE 452 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 332
TABLE 453 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 332
11.5.1 BRAZIL 332
11.5.1.1 Growth of vaccine manufacturing to drive market 332
TABLE 454 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 333
TABLE 455 BRAZIL: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 333
TABLE 456 BRAZIL: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 334
TABLE 457 BRAZIL: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 334
TABLE 458 BRAZIL: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 335
TABLE 459 BRAZIL: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 335
TABLE 460 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 335
TABLE 461 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 336
TABLE 462 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 336
TABLE 463 BRAZIL: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 337
TABLE 464 BRAZIL: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 337
TABLE 465 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 338
11.5.2 REST OF LATIN AMERICA 338
TABLE 466 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 338
TABLE 467 ROLATAM: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 339
TABLE 468 ROLATAM: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 339
TABLE 469 ROLATAM: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 340
TABLE 470 ROLATAM: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 340
TABLE 471 ROLATAM: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 340
TABLE 472 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 341
TABLE 473 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 341
TABLE 474 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 341
TABLE 475 ROLATAM: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 342
TABLE 476 ROLATAM: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 342
TABLE 477 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 343
11.5.3 LATIN AMERICA: RECESSION IMPACT 343
11.6 MIDDLE EAST & AFRICA 344
11.6.1 SLOW AND EVOLVING BIOPHARMACEUTICAL INDUSTRY AND REGULATIONS TO HAMPER MARKET GROWTH 344
TABLE 478 MEA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 344
TABLE 479 MEA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 345
TABLE 480 MEA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 345
TABLE 481 MEA: DEPTH FILTERS MARKET, BY MEDIA, 2021–2028 (USD MILLION) 346
TABLE 482 MEA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021–2028 (USD MILLION) 346
TABLE 483 MEA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 346
TABLE 484 MEA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 347
TABLE 485 MEA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 347
TABLE 486 MEA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 347
TABLE 487 MEA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021–2028 (USD MILLION) 348
TABLE 488 MEA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021–2028 (USD MILLION) 348
TABLE 489 MEA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021–2028 (USD MILLION) 349
11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 349
12 COMPETITIVE LANDSCAPE 350
12.1 INTRODUCTION 350
12.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 350
FIGURE 33 PHARMACEUTICAL FILTRATION MARKET: STRATEGIES ADOPTED 351
12.3 MARKET SHARE ANALYSIS 352
FIGURE 34 PHARMACEUTICAL FILTRATION MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2022) 352
TABLE 490 PHARMACEUTICAL FILTRATION MARKET: DEGREE OF COMPETITION 353
12.4 REVENUE ANALYSIS 354
FIGURE 35 REVENUE ANALYSIS FOR KEY COMPANIES (2020–2022) 354
12.5 COMPANY EVALUATION MATRIX 354
FIGURE 36 PHARMACEUTICAL FILTRATION MARKET: COMPANY EVALUATION MATRIX, 2022 355
12.5.1 STARS 356
12.5.2 EMERGING LEADERS 356
12.5.3 PERVASIVE PLAYERS 356
12.5.4 PARTICIPANTS 356
12.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 357
12.6.1 OVERALL FOOTPRINT OF COMPANIES (25 COMPANIES) 357
TABLE 491 FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET 357
12.6.2 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES) 358
TABLE 492 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET 358
12.6.3 TECHNIQUE FOOTPRINT OF COMPANIES (25 COMPANIES) 359
TABLE 493 TECHNIQUE FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET 359
12.6.4 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 360
TABLE 494 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET 360
12.7 COMPANY EVALUATION MATRIX: START-UPS/SMES 361
FIGURE 37 PHARMACEUTICAL FILTRATION MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 361
12.7.1 PROGRESSIVE COMPANIES 362
12.7.2 STARTING BLOCKS 362
12.7.3 RESPONSIVE COMPANIES 362
12.7.4 DYNAMIC COMPANIES 362
12.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES 363
TABLE 495 PHARMACEUTICAL FILTRATION MARKET: DETAILED LIST OF KEY START-UPS/SMES 363
TABLE 496 PHARMACEUTICAL FILTRATION MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 364
12.9 COMPETITIVE SCENARIO AND TRENDS 364
12.9.1 PRODUCT LAUNCHES 364
TABLE 497 PHARMACEUTICAL FILTRATION MARKET: PRODUCT LAUNCHES, JANUARY 2019 TO JANUARY 2023 365
12.9.2 DEALS 366
TABLE 498 PHARMACEUTICAL FILTRATION MARKET: DEALS, JANUARY 2019 TO JANUARY 2023 366
12.9.3 EXPANSIONS 368
TABLE 499 PHARMACEUTICAL FILTRATION MARKET: EXPANSIONS, JANUARY 2019 TO JANUARY 2023 368

13 COMPANY PROFILES 370
13.1 KEY PLAYERS 370
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 MERCK KGAA 370
TABLE 500 MERCK KGAA: BUSINESS OVERVIEW 370
FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2021) 371
13.1.2 DANAHER CORPORATION 376
TABLE 501 DANAHER CORPORATION: BUSINESS OVERVIEW 376
FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 377
13.1.3 SARTORIUS AG 384
TABLE 502 SARTORIUS AG: BUSINESS OVERVIEW 384
FIGURE 40 SARTORIUS AG: COMPANY SNAPSHOT (2021) 385
13.1.4 PARKER HANNIFIN CORPORATION 390
TABLE 503 PARKER HANNIFIN CORPORATION: BUSINESS OVERVIEW 390
FIGURE 41 PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2022) 391
13.1.5 EATON CORPORATION PLC 394
TABLE 504 EATON CORPORATION PLC: BUSINESS OVERVIEW 394
FIGURE 42 EATON CORPORATION PLC: COMPANY SNAPSHOT (2021) 395
13.1.6 THERMO FISHER SCIENTIFIC, INC. 398
TABLE 505 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 398
FIGURE 43 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021) 399
13.1.7 3M COMPANY 403
TABLE 506 3M COMPANY: BUSINESS OVERVIEW 403
FIGURE 44 3M COMPANY: COMPANY SNAPSHOT (2021) 404
13.1.8 DONALDSON COMPANY, INC. 408
TABLE 507 DONALDSON COMPANY, INC.: BUSINESS OVERVIEW 408
FIGURE 45 DONALDSON COMPANY, INC.: COMPANY SNAPSHOT (2022) 409
13.1.9 REPLIGEN CORPORATION 412
TABLE 508 REPLIGEN CORPORATION: BUSINESS OVERVIEW 412
FIGURE 46 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2021) 413
13.1.10 PORVAIR PLC 416
TABLE 509 PORVAIR PLC: BUSINESS OVERVIEW 416
FIGURE 47 PORVAIR PLC: COMPANY SNAPSHOT (2021) 417
13.1.11 ALFA LAVAL CORPORATE AB 420
TABLE 510 ALFA LAVAL CORPORATE AB: BUSINESS OVERVIEW 420
FIGURE 48 ALFA LAVAL CORPORATE AB: COMPANY SNAPSHOT (2021) 421
13.1.12 CORNING INCORPORATED 424
TABLE 511 CORNING INCORPORATED: BUSINESS OVERVIEW 424
FIGURE 49 CORNING INCORPORATED: COMPANY SNAPSHOT (2021) 425
13.1.13 MEISSNER FILTRATION PRODUCTS, INC. 427
TABLE 512 MEISSNER FILTRATION PRODUCTS, INC.: BUSINESS OVERVIEW 427
13.1.14 AMAZON FILTERS LTD. 430
TABLE 513 AMAZON FILTERS LTD.: BUSINESS OVERVIEW 430
13.1.15 GRAVER TECHNOLOGIES, LLC. 433
TABLE 514 GRAVER TECHNOLOGIES, LLC.: BUSINESS OVERVIEW 433
13.2 OTHER COMPANIES 435
13.2.1 MMS AG 435
13.2.2 MANN+HUMMEL INTERNATIONAL GMBH & CO. KG 436
13.2.3 ERTELALSOP 437
13.2.4 KASAG SWISS AG 438
13.2.5 FREUDENBERG FILTRATION TECHNOLOGIES SE & CO. KG 439
13.2.6 COLE-PARMER INSTRUMENT COMPANY, LLC 440
13.2.7 CANTEL MEDICAL CORP. 441
13.2.8 FILTROX AG 442
13.2.9 SAINT-GOBAIN PERFORMANCE PLASTICS 443
13.2.10 MEMBRANE SOLUTIONS 444
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 445
14.1 DISCUSSION GUIDE 445
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 450
14.3 CUSTOMIZATION OPTIONS 452
14.4 RELATED REPORTS 453
14.5 AUTHOR DETAILS 454

★調査レポート[世界の医薬品ろ過市場(~2028年):製品別(メンブレン、デプスフィルター)、用法別(使い捨て型、再利用型)、技術別(精密ろ過、ナノろ過)、用途別(API、ワクチン、抗体)、使用規模別(製造、パイロット、研究開発)、地域別] (コード:BT4058-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の医薬品ろ過市場(~2028年):製品別(メンブレン、デプスフィルター)、用法別(使い捨て型、再利用型)、技術別(精密ろ過、ナノろ過)、用途別(API、ワクチン、抗体)、使用規模別(製造、パイロット、研究開発)、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆